We serve Chemical Name:(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide CAS:1235370-13-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide](https://a.dearchem.com/CAS2/1235370-13-4.png)
Chemical Name:(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide
CAS.NO:1235370-13-4
Synonyms:(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide
Molecular Formula:C19H14F3N3O3
Molecular Weight:389.32800
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.41
Index of Refraction:
PSA:109.63000
Exact Mass:389.09900
LogP:3.86676
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide Use and application,(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide technical grade,usp/ep/jp grade.
Related News: Stem cell transplants from matched, related donors can be effective, but most patients don’t have such donors available to them. N,1-bis(4-methoxyphenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carboxamide manufacturers “Alcami supported this product with supply constraints and successfully developed a capsule formulation for two dosage strengths,” she explains. “The formulations group performed studies at a micro-laboratory scale using a scientifically-based approach to identify a lead prototype. guanidine,5-oxo-1-(4-sulfophenyl)-4-[(4-sulfophenyl)diazenyl]-4H-pyrazole-3-carboxylic acid,hydrochloride suppliers EMA said it considered that the results of the clinical studies used to support the application “were inconsistent and did not satisfactorily show that Nouryant was effective at reducing the ‘off’ time. 11-(N,N-dipentyl-glycyl)-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one vendor & factory.
